| Anti-Schistosomiasis Sm14-vaccine in Senegal (NCT05658614) | Oswaldo Cruz Foundation | 2022-07-01 |
| Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine (NCT05315362) | Leiden University Medical Center | 2022-05-01 |
| Post Covid-19 Vaccination Development or Flare of ARD (NCT05160428) | Cairo University | 2022-02-01 |
| The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort (NCT04970836) | National Taiwan University Hospital | 2021-08-01 |
| Monitoring COVID-19 Vaccination Response in Fragile Populations (NCT05222139) | University of Bologna | 2021-05-24 |
| Risk of COVID-19 Infection After Vaccination (NCT04848441) | Umeå University | 2021-05-01 |
| Immune Response to Vaccination Against Covid-19, a Follow up Study (NCT04920357) | Umeå University | 2021-03-31 |
| Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old (NCT05470582) | St. Petersburg Research Institute of Vaccines and Sera | 2021-02-16 |
| Maternal Determinants of Immunity to Influenza (NCT06716567) | Centre Hospitalier Universitaire Saint Pierre | 2020-11-16 |
| Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine (NCT05869201) | St. Petersburg Research Institute of Vaccines and Sera | 2020-10-06 |
| COVID-19 Serology in People Living with HIV in Hong Kong (NCT05028881) | Chinese University of Hong Kong | 2020-05-16 |
| Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women (NCT05457894) | St. Petersburg Research Institute of Vaccines and Sera | 2020-01-23 |
| Mood and Influenza Vaccine Response: A Feasibility Trial (NCT03144518) | University of Nottingham | 2017-09-01 |